期刊文献+

氨肽酶抑制剂对人白血病细胞株凋亡的研究 被引量:5

Study of human leukemic cell lines by aminopeptidase inhibitor
下载PDF
导出
摘要 目的 探索氨肽酶抑制剂对体外培养人红白血病细胞株K5 62作用及其机制。方法 应用四甲基偶氮唑蓝 (MTT)法、荧光显微镜、透射电检测镜、流式细胞仪观察氨肽酶抑制剂对人红白血病细胞株K5 62生长的影响。结果 氨肽酶抑制剂能明显抑制白血病细胞生长 ,其半数生长抑制剂量为 2 8.8μg/ml;透射电镜超微结构证实氨肽酶抑制剂能诱发肿瘤细胞凋亡的典型形态变化 ;流式细胞仪检测证实氨肽酶抑制剂可诱发细胞凋亡 ;免疫组化SP法及流式细胞仪定量分析发现氨肽酶抑制剂能使癌基因Bcl 2表达降低、抑癌基因P53表达增强。结论 氨肽酶抑制剂能诱导K5 62细胞凋亡 ,其作用机制可能与癌基因Bcl 2表达减少。 Objective To explore the function and mechanism of aminopeptidase inhibitor for extracorporeal cultivating human erythroleukemia cell line K562. Methods Methyl thiazolyl tetrazolivm method,fluorescence microscope, transmission electronic mirror and stream-cell meter were used to observe the influence of aminopeptidase inhibitor on upgrowth of human erythroleukemia cell line K562.Results Aminopeptidase inhibitor could markedly restrain leukemia cell hyperplasia with the half dose of upgrowth inhibitor 28.8 μg/ml, which validated in detail that aminopeptidase inhibitor could induce the typical configuration change in apoptosis of tumor cells by the ultrastructure of transmission electronic mirror; it could induce cell apoptosis by stream-cell meter and decrease cancer gene Bcl-2 expression and increase P 53 tumor suppressor gene by immunity group SP method and stream-cell meter through quantitative analysis. Conclusion Aminopeptidase inhibitor can induce the apotosis of K562 cell which bears relation to cancer gene Bcl-2 expression reduction and P 53 expression increase.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2003年第5期353-355,共3页 Journal of Applied Clinical Pediatrics
关键词 氨肽酶抑制剂 肿瘤细胞凋亡 K562细胞 红白血病细胞株 aminopeptidase inhibitor apoptosis K562 cell
  • 相关文献

参考文献5

二级参考文献17

共引文献34

同被引文献27

  • 1贾国存,汤有才,廖清奎,房定珠,李丰益,袁粒星.铁剥夺对白血病细胞凋亡相关基因表达的影响[J].实用儿科临床杂志,2005,20(1):16-17. 被引量:8
  • 2陈力军,张太娥,王红美,高飞,顾艳.叶酸对人T淋巴细胞性白血病细胞体外的作用[J].实用儿科临床杂志,2005,20(5):443-445. 被引量:2
  • 3王亚平,祝彼得.当归多糖对造血祖细胞增殖调控机理的研究[J].中华医学杂志,1996,76(5):363-366. 被引量:49
  • 4王振义 陈竺.肿瘤的诱导分化治疗和凋亡疗法[M].上海:上海科学技术出版社,1997.46-47.
  • 5Thongprasert S,Chewaskulyong B.Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic nonsmall cell lung cancer[J].J Med Assoc Thai,2004,87(10):1162-1167.
  • 6Fisher M J,Lange BJ,Needle MN,et al.Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy[J].Pediatr Blood Cancer,2004,43(7):780-784.
  • 7Mantovani G,Maccio A,Madeddu C,et al.The impact of different antioxidant agents alone or in combination on reactive oxygen species,antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites:correlation with disease progression[J].Free Radic Res,2003,37(2):213-223.
  • 8Dragojevic-Simic VM,Dobric SL,Bokonjic DR,et al.Amifostine protection against doxorubicin cardiotoxicity in rats[J].Anticancer Drugs,2004,15(2):169-178.
  • 9Klastersky J.Side effects of ifosfamide[J].Oncology,2003,65(2suppl):S7-S10.
  • 10Kemp CJ,Sun S,Gurley KE.P53 induction and apoptosis in response to radio- and chemo-therapy in vivo is tumor-type-dependent [J].Cancer Res,2001,61(1):327-332.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部